Better access to drugs in developing countries is accelerating resistanceBMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c3234 (Published 17 June 2010) Cite this as: BMJ 2010;340:c3234
- Susan Mayor
Improving access to drugs to treat serious diseases common in developing countries, including malaria, HIV, and tuberculosis, is having the unintended effect of speeding up the development of microbial resistance to drugs, warns a new report.
The report, published on 15 June by the Center for Global Development, shows a close link between the volume of drug use and the emergence of resistant strains, particularly in settings without adequate systems for ensuring appropriate use of drugs. For example, in countries with the highest use of antibiotics, 75% to 90% of strains of Streptococcus pneumoniae are resistant to commonly …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial